Novan to Present at Piper Jaffray 30th Annual Healthcare Conference
MORRISVILLE, N.C., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that Paula Brown Stafford, Chief Development Officer, and Nathan Stasko, President and Chief Scientific Officer, are scheduled to participate in a fireside chat at the Piper Jaffray 30th Annual Healthcare Conference on Wednesday, November 28, 2018, at 12:00 p.m. Eastern Time, in New York.
Audio of the presentation will be webcast live and can be accessed through the Investor Relations section of the Company’s website at www.Novan.com. An archived version of the webcast will be available approximately two hours following the live presentation for 30 days.
Novan, Inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. We believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in a variety of diseases.
(Investors)Cole IkkalaDirector, Investor Relations, Capital Sourcing & Relationships email@example.com
(Media)Cari GreenDirector, Corporate Communications and Administration firstname.lastname@example.org